p53 regulation of metabolic pathways
- PMID: 20452943
- PMCID: PMC2845207
- DOI: 10.1101/cshperspect.a001040
p53 regulation of metabolic pathways
Abstract
During the course of tumorigenesis, cells acquire a number of alterations that contribute to the acquisition of the malignant phenotype, allowing them to survive and flourish in increasingly hostile environments. Cancer cells can be characterized by perturbations in the control of cell proliferation and growth, resistance to death, and alterations in their interactions with the microenvironment. Underpinning many of these changes are shifts in metabolism that allow cancer cells to use alternative pathways for energy production and building the macromolecules necessary for growth, as well as regulating the generation of signaling molecules such as reactive oxygen species (ROS). In the past few years, it became clear that p53, the most studied, if not most important, tumor suppressor protein, can also directly control metabolic traits of cells.
Figures


References
-
- An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM 1998. Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature 392:405–408 - PubMed
-
- Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–120 - PubMed
-
- Bertheau P, Espie M, Turpin E, Lehmann J, Plassa L-F, Varna M, Janin A, de The H 2008. TP53 status and response to chemotherapy in breast cancer. Pathobiology 75:132–139 - PubMed
-
- Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L 1998. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273:11995–11998 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous